Is CBLL or CNMD more undervalued in 2026?

CirclFi compares CeriBell, Inc. (CBLL) and CONMED Corporation (CNMD) using 13 institutional-grade valuation models. CBLL has a Quality of Company score of 6.8/10 while CNMD scores 8.3/10.

Which is a better buy — CBLL or CNMD?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do CBLL and CNMD valuations compare?

CBLL at $18.45 and CNMD at $35.70 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

CBLL vs CNMD Valuation Comparison 2026 — Intrinsic Value Analysis

CBLL

Electromedical & Electrotherapeutic Apparatus

CeriBell, Inc.

Quality

6.8

out of 10

Value Trap

SAFE

Price

$18.45

Last close

Models

11/13

Active

CNMD

Electromedical & Electrotherapeutic Apparatus

CONMED Corporation

Quality

8.3

out of 10

Value Trap

—

Price

$35.70

Last close

Models

11/13

Active

Model-by-Model Comparison

Model	Type	CBLL Fair Value	CBLL Upside	CNMD Fair Value	CNMD Upside
Bayesian DCF	Intrinsic	$5.15	-72.1%	$19.68	-44.9%
Earnings Power Value	Intrinsic	$3.50	-82.9%	—	—
EROIC Spread	Intrinsic	$0.59	-96.8%	$22.65	-36.6%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for CBLL vs CNMD — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

CBLL vs CNMD — Which Stock Is More Undervalued?

CNMD scores higher with a 8.3/10 quality rating vs CBLL's 6.8/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing CeriBell, Inc. (CBLL) and CONMED Corporation (CNMD) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

CBLL currently trades at $18.45 with a QOC of 6.8/10, while CNMD trades at $35.70 with a QOC of 8.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).